PERJETA

Google image searchProduct monograph

Active ingredient

pertuzumab, 420 MG/14 ML

DIN: 02405016

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: 14ML VIAL - CONCENTRATE SOL.

Schedule: Prescription / Schedule D

Company: HOFFMANN-LA ROCHE LIMITED

Date: 08-MAY-2013

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
• L01FD — HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors (ATC, ATC/DDD)
• L01FD02 — PERTUZUMAB (ATC/DDD)

Reference brand drug: Perjeta

External Links for Perjeta

Search on Google

• Perjeta side effects
• Perjeta dosage
• pertuzumab side effects
• pertuzumab dosage

Hoffmann-La Roche Limited

Go to Hoffmann-La Roche website to see drug product details. Sometimes you can find perjeta photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.